HMHagerah S. Malik

Hagerah S. Malik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Hagerah S. Malik has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra Y. Soare

    Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA

    1 shared publication
  • Benjamin K. Chen

    Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    1 shared publication
  • Catarina E. Hioe

    Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    1 shared publication
  • Chitra Upadhyay

    Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    1 shared publication
  • Foramben Patel

    Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    1 shared publication
  • Namita Satija

    Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    1 shared publication

Latest Publications

  • P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion

    by Alexandra Y. Soare, Hagerah S. Malik, Natasha D. Durham, Tracey L. Freeman, Raymond Alvarez, Foramben Patel, Namita Satija, Chitra Upadhyay, Catarina E. Hioe, Benjamin K. Chen, et al.

    While effective treatment can lower the severe morbidity and mortality associated with HIV-1 infection, patients infected with HIV-1 suffer from significantly higher rates of noncommunicable comorbidities associated with chronic inflammation. Emerging literature suggests a key role for P2X1 receptors in mediating this chronic inflammation, but the mechanism is still unknown. Here, we demonstrate that HIV-1 infection is reduced by P2X1 receptor antagonism. This inhibition is mediated by interference with HIV-1 Env and can impact a variety of viral clades. These observations highlight the importance of P2X1 antagonists as potential novel therapeutics that could serve to block a variety of different viral clades with additional benefits for their anti-inflammatory properties.